Why do obese people get cancer more often? How can some turtles live more than a century without ever developing tumors while mice can develop them in a year? Could treatments that hold tumor cells in check without destroying them keep people alive longer?
By the time his twins Noah and Alexis were 12 years old, Joe Beery and his wife Retta had spent a decade trying to figure out what made their children so ill. After Joe took a job at Life Technologies Corp., a California company that makes DNA sequencers, their luck turned.
Five corporate executives and seven university leaders discussed with John Holdren, President Barack Obama’s science adviser, and David Kappos, head of the U.S. Patent and Trademark Office, ways to boost the economy through promoting innovation during an Oct. 5 event in Washington sponsored by Harvard University and the Business Roundtable and hosted by Bloomberg News.
Doctors are treating cancer according to the genetic aberrations found in patients’ tumors, not just where they’re found in the body, an approach that may boost the odds of survival, according to a study.
The U.S. spends more than any other nation on biomedical research, counting on those outlays to make health care more efficient. Leading the way is the National Institutes of Health, which funds more than $30 billion on projects each year, chiefly in basic research.